Suppr超能文献

靶向恶性疟原虫感染的人类红细胞的离子通道用于抗疟药物研发。

Targeting ion channels of Plasmodium falciparum-infected human erythrocytes for antimalarial development.

作者信息

Desai Sanjay A

机构信息

Bldg. 4, Room 126, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.

出版信息

Curr Drug Targets Infect Disord. 2004 Mar;4(1):79-86. doi: 10.2174/1568005043480934.

Abstract

Aside from its profound clinical importance, the human malaria parasite, P. falciparum, is intrinsically fascinating to the cell biologist because it resides within the mature red blood cell (RBC). Because the inert RBC cannot otherwise provide sufficient amounts of key substrates to fuel the vigorous parasite metabolism, the parasite must have specialized adaptations for getting these solutes into the RBC and scavenging them from RBC cytosol. Two unusual ion channels have recently been identified within the infected RBC complex; these channels likely function in a sequential diffusive pathway of nutrient acquisition by the intracellular parasite. If so, they present novel opportunities for identification of ion channel inhibitors that may be useful antimalarial compounds.

摘要

除了其深远的临床重要性外,人类疟原虫恶性疟原虫对细胞生物学家来说本质上也极具吸引力,因为它寄生于成熟红细胞(RBC)内。由于惰性的红细胞无法以其他方式提供足够量的关键底物来支持活跃的寄生虫代谢,寄生虫必须有专门的适应性机制,以便将这些溶质转运到红细胞内,并从红细胞胞质溶胶中清除它们。最近在受感染的红细胞复合体中发现了两种不同寻常的离子通道;这些通道可能在细胞内寄生虫获取营养的顺序扩散途径中发挥作用。如果是这样,它们为鉴定可能是有用抗疟化合物的离子通道抑制剂提供了新的机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验